Log In
Sunday 25th June 2017

Flu vaccine development

4th May 2006

The U.S. Health and Human Services Department have awarded five companies, including GlaxoSmithKline, more than $1 billion (540 million pounds) in contracts to develop new and better influenza vaccines.

The companies will all work to develop cell based-vaccines to fight influenza; GlaxoSmithKline was awarded $274.75 million (148.60 million pounds), MedImmune was awarded $169.46 million, Novartis AG won $220.51 million, DynPort vaccine, working with Baxter International Inc. , won $40.97 million and Solvay won $298.59 million.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: Flu vaccine development
Author: Sue Knights
Article Id: 273
Date Added: 4th May 2006


News Now

Recent Related Articles

South Korea downgrade bird flu status

Six new bird flu cases reported in China


Add to scrapbook
Show Comments
Add comment
Find all related articles


M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2017